“If my patients are happy on drops, why intervene surgically?” It’s one question on every glaucoma specialist’s mind, and one that sparks serious debate.
At ESCRS, Nova Eye gathered leading minds—Dr. Ike Ahmed, Dr. Larissa Camejo, Prof. Henny Beckers and Dr. I. Paul Singh—to tackle this burning question in interventional glaucoma.
Armed with insights, data and a healthy dose of candor, these experts explored why MIGS (and canaloplasty with iTrack™ Advance) may deserve a place sooner in the treatment journey…even for those “happy on drops.”
From rethinking medication use to redefining what “controlled glaucoma” really means, these experts did not hold back. Watch now and visit https://itrack-advance.com/ for more information.
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
